Molekin D3 + K2 + MgB6 (60 Tablets)
Molekin D3 + K2 + MgB6 is a dietary supplement for adults, containing vitamin D in the dose recommended by experts (2000 IU), vitamin K2-MK7 as well as magnesium (200 mg) and vitamin B6 (2 mg).
- Vitamins D and K and magnesium help maintain healthy bones.
- Vitamin D and magnesium help maintain healthy teeth.
- Vitamin D contributes to the proper use of calcium and phosphorus, maintains the correct level of calcium in the blood, and contributes to the proper functioning of the immune system.
- Magnesium helps maintain healthy bones and teeth and plays a role in the process of cell division, and vitamin B6 contributes to the regulation of hormonal activity and helps in the proper production of red blood cells.
- Magnesium and vitamin B6 contribute to the maintenance of proper energy metabolism and help in the proper functioning of the nervous system. In addition, they contribute to reducing the feeling of fatigue and weariness.
Symptoms
The preparation is intended for adults who want to support the functioning of the immune system, nervous system and healthy bones.
Recommended daily dose
2 tablets a day.
Composition
Ingredient | 1 tablet |
Vitamin D | 50 mg (1000% RWS *) |
Vitamin K. | 75 mg (100% RWS *) |
Vitamin B6 | 2 mg (143% RWS *) |
Magnesium | 200 mg (53% RWS *) |
* NRV- nutrient reference value
Application notes
Dietary supplements do not replace a balanced diet and a healthy lifestyle. The product cannot be used as a substitute for a varied diet. Dietary supplements should be stored out of reach of small children.
Be especially careful:
- If allergic reactions of any type to products containing vitamins D and K have been reported.
- If you have hypervitaminosis D (too much vitamin D in the blood).
- If warfarin derivatives or low-dose aspirin are used to thin the blood.
- If you are prone to blood clots. Do not use in the course of tuberculosis, sarcoidosis, some types of lymphomas.
Contents
60 tablets
Manufacturer
NP PHARMA
Storage
Below 25°C
Reviews
There are no reviews yet.